Pharmaceutical ProductCached Profile
GENERAL THERAPIES
Active Ingredients (Generic):Unmapped
Therapeutic Area: THERAPIES
LIFETIME PROMOTIONAL SPEND
$8,296
General Payments Aggregated (2021–2024)
Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
FDA Patient Safety Profile
Dynamic safety indicators compiled from official FDA product labels.
Active Clinical Trials
Clinical studies listing this drug as an active intervention.
Association Between Thrombin Generation Parameters and the Risk of Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis (CAT) (a Multicenter Study)
RECRUITINGPhase NANCT06386107
Effects of Cognitive Behavioural Therapy for Insomnia (CBT-I) on Impulsivity and Risk Taking in Youths With Insomnia: A Randomised Controlled Trial
RECRUITINGPhase NANCT07399964
Feasibility and Acceptability Study of "Mamá, te Entiendo": an App-based Intervention for Reducing Depressive Symptoms in Postpartum Women
UNKNOWNPhase NANCT05643898
Effect of the 4-7-8 Breathing Technique on Pain and Nausea-Vomiting in Patients After Bariatric Surgery
COMPLETEDPhase NANCT06439121
Top Funded Physicians (Cumulative)
Doctors receiving the highest aggregate promotional support for this product.
Dr. ARON CHARYMedical Doctor$2,741
Dr. LAUREN DRAKEMedical Doctor$876
Dr. JOHNATHAN LINDQUISTMedical Doctor$600
Dr. MENA YACOUBMedical Doctor$541
Dr. CARLA COLON NUNEZMedical Doctor$272
Drug Marketing Payments Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2024
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for GENERAL THERAPIES...